22nd Century Group, Inc.

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Technology
    • Our Tobacco Technology
    • Our Cannabis/Hemp Technology
  • VLN Clinical Studies
    • Published Clinical Studies
    • On-Going Clinical Studies
    • Commentaries & Opinion
  • Products
    • SPECTRUM® Variable Nicotine Research Cigarettes
    • Moonlight®
    • VLN®
  • Investors
    • Overview
    • News
    • Events
    • Stock Data
    • SEC Filings / XBRL
    • Corporate Governance
    • Annual Reports
    • FAQs
  • News
    • Press Releases
  • Contact Us

Press Releases

News

News

  • Press Releases
Dec 23, 2019 3:39pm EST

22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee

Dec 17, 2019 1:34pm EST

FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol Cigarettes

Dec 13, 2019 4:03pm EST

22nd Century Group Announces Management Changes

Dec 03, 2019 5:24pm EST

22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.

Nov 21, 2019 8:51am EST

22nd Century Group Comments on Delay of Reduced Nicotine Rule for Cigarettes

Nov 07, 2019 4:30pm EST

22nd Century Group Files 2019 Third Quarter Report

Nov 04, 2019 4:06pm EST

22nd Century Group Announces Webcast to Provide Business Update

Aug 07, 2019 4:15pm EDT

22nd Century Group Files 2019 Second Quarter Report

Aug 05, 2019 7:00am EDT

22nd Century Group Appoints Cliff Fleet Chief Executive Officer

Aug 02, 2019 7:00am EDT

22nd Century Group Announces Conference Call to Provide Business Update

RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...28
    Next
    © 2021 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap